Toggle navigation
Home
Medical
Oral JAK1 Inhibitor Shows Promise for Hidradenitis Suppurativa
27-1-2021
Medical
https://www.medscape.com/cx/rssfeeds/2700.xml
111
The investigational oral small molecule, known for now as INCB54707, is 52 times more selective for JAK1 than JAK2. Medscape Medical News
Share
Tweet
+1
Read The Rest
at : https://www.medscape.com/cx/rssfeeds/2700.xml
Related News
Hope Shines Bright for Hidradenitis Suppurativa Treatments
Monkeypox Outbreak Slows as Feds Promise Action, Outreach
Blood Test Shows Promise for Quick Diagnosis of ALS
Study shows hay fever among school children leads to...
Incarceration associated with higher cancer mortality,...
Overexpressed Cyclin D1 and CDK4 proteins are responsible...
Talking Teeth – improving oral health anytime, anywhere
Oral melanoma: a multicenter study of 69 patients from Japan
Research reveals cetylpyridinium chloride in mouthwash...
Study shows rapid waning of immune protection due to...